These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 1683283)
1. Toxicology testing requirements and the U.S.-Japan collaborative study on in vitro tests for chromosomal aberrations. Shelby MD; Sofuni T Environ Health Perspect; 1991 Aug; 94():255-9. PubMed ID: 1683283 [TBL] [Abstract][Full Text] [Related]
2. Regulatory aspects of genotoxicity testing: from hazard identification to risk assessment. Blakey D; Galloway SM; Kirkland DJ; MacGregor JT Mutat Res; 2008 Nov; 657(1):84-90. PubMed ID: 18926925 [TBL] [Abstract][Full Text] [Related]
6. The Japanese mutagenicity studies guidelines for pesticide registration. Shirasu Y Mutat Res; 1988; 205(1-4):393-5. PubMed ID: 3367923 [No Abstract] [Full Text] [Related]
7. [Cytogenetic effects of gaseous and volatile chemicals on mammalian cells in vitro and in vivo. I. Chromosome aberration tests in cultured mammalian cells]. Sofuni T; Hayashi M; Matsuoka A; Sawada M; Hatanaka M; Ishidate M Eisei Shikenjo Hokoku; 1984; (102):77-83. PubMed ID: 6532510 [No Abstract] [Full Text] [Related]
8. Genotoxicity guidelines recommended by International Conference of Harmonization (ICH). Kamath GH; Rao KS Methods Mol Biol; 2013; 1044():431-58. PubMed ID: 23896892 [TBL] [Abstract][Full Text] [Related]
9. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes. Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131 [TBL] [Abstract][Full Text] [Related]
10. Harmonization of genotoxicity testing requirements for pharmaceuticals. Sofuni T J Toxicol Sci; 1998 Jul; 23 Suppl 2():262-4. PubMed ID: 9760479 [No Abstract] [Full Text] [Related]
11. In vivo methods for evaluating genotoxicity. Swenberg JA Dev Toxicol Environ Sci; 1980; 8():165-70. PubMed ID: 7308018 [No Abstract] [Full Text] [Related]
12. The role of mammalian cell mutation assays in mutagenicity and carcinogenicity testing. Arlett CF; Cole J Mutagenesis; 1988 Nov; 3(6):455-8. PubMed ID: 3070282 [No Abstract] [Full Text] [Related]
13. [Carcinogen screening in mammalian cells in vitro. The clastogenicity and the SCE test]. Thust R Zentralbl Allg Pathol; 1984; 129(4):365-70. PubMed ID: 6395564 [TBL] [Abstract][Full Text] [Related]
14. Mutagenicity assessment of acrylate and methacrylate compounds and implications for regulatory toxicology requirements. Johannsen FR; Vogt B; Waite M; Deskin R Regul Toxicol Pharmacol; 2008 Apr; 50(3):322-35. PubMed ID: 18346829 [TBL] [Abstract][Full Text] [Related]
15. The in vitro mammalian chromosome aberration test. Clare G Methods Mol Biol; 2012; 817():69-91. PubMed ID: 22147569 [TBL] [Abstract][Full Text] [Related]
16. The interpretation and analysis of cytogenetic data. Danford N Methods Mol Biol; 2012; 817():93-120. PubMed ID: 22147570 [TBL] [Abstract][Full Text] [Related]
17. [Genetic toxicology and occupational medicine: prospects of its use]. Laurent C Rev Med Liege; 1986 Mar; 41(6):209-16. PubMed ID: 3518009 [No Abstract] [Full Text] [Related]
18. Mutation research, genetic toxicology and environmental mutagenesis. Nestmann ER Mutat Res; 2005 Mar; 581(1-2):191-2; author reply 193-6. PubMed ID: 15725619 [No Abstract] [Full Text] [Related]
20. Effect of reducing the top concentration used in the in vitro chromosomal aberration test in CHL cells on the evaluation of industrial chemical genotoxicity. Morita T; Honma M; Morikawa K Mutat Res; 2012 Jan; 741(1-2):32-56. PubMed ID: 22020093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]